For years, a diagnosis of cystic fibrosis has often meant an early death for patients. This week, Cystic Fibrosis Canada released its annual data report this week for 2021. A new drug, Trikafta, is keeping patients out of hospitals and off of transplant lists.
The Globe’s health reporter Kelly Grant explains why doctors are now talking about cystic fibrosis as a disease in transition and the hope of a new future for thousands of patients.
Questions? Comments? Ideas? Email us at thedecibel@globeandmail.com
